$LIVN 4 SEC Filings

Filed On	Filing
16 Sep 2026	Form 4: Liddy Anne M., Chief Legal Officer Granted 6,291 Restricted Stock Units
14 Sep 2026	Form 4: Bianchi Francesco, Director Sold 3,500 shares ($273K)
08 Sep 2026	Form 4: Story Brooke, Director Sold 2,300 shares ($187K)
02 Sep 2026	Form 4: Bianchi Francesco, Director Sold 1,650 shares ($132K)
13 Aug 2026	Form 4: Tezel Ahmet, Chief Innovation Officer Received 12,692 shares by exercise or conversion ($669K) · Returned 8,589 shares to the issuer ($669K) · Gave up 1,428 shares to cover exercise price or tax ($111K) · 1 more
17 Jun 2026	Form 4: Wilver Peter M, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Schermerhorn Todd C, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Bianchi Francesco, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Sold 1,200 shares ($96.2K) · 1 more
17 Jun 2026	Form 4: Podlogar Susan M, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Barry James Christopher, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Tezel Ahmet, Chief Innovation Officer Received 2,965 shares by exercise or conversion · Gave up 1,032 shares to cover exercise price or tax ($82.3K)
17 Jun 2026	Form 4: Nygaard-Andersen Jette, Director Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Kozy William A, Director Received 5,681 shares by exercise or conversion · Gave up 682 shares to cover exercise price or tax ($54.4K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Enxing Seng Stacy, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Story Brooke, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Zurbay Donald, Director Received 2,560 shares by exercise or conversion · Gave up 308 shares to cover exercise price or tax ($24.5K) · Granted 2,383 Restricted Stock Units
27 May 2026	Form 4: Bianchi Francesco, Director Sold 1,800 shares ($136K)
01 Apr 2026	Form 4: Tezel Ahmet, Chief Innovation Officer Received 3,408 shares by exercise or conversion · Gave up 1,186 shares to cover exercise price or tax ($72.7K) · Granted 13,873 Restricted Stock Units · 1 more
01 Apr 2026	Form 4: Poletti Franco, President, Cardiopulmonary Received 3,184 shares by exercise or conversion · Gave up 1,370 shares to cover exercise price or tax ($83.9K)
01 Apr 2026	Form 4: Shvartsburg Alex, Chief Financial Officer Received 30,835 shares by exercise or conversion · Gave up 12,868 shares to cover exercise price or tax ($788K) · Granted 16,321 Restricted Stock Units · 1 more

Comments